You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Travoprost - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for travoprost and what is the scope of freedom to operate?

Travoprost is the generic ingredient in five branded drugs marketed by Glaukos, Novartis, Alcon Pharms Ltd, Sandoz, Alembic, Apotex, Chartwell Rx, Micro Labs, and Mylan, and is included in nine NDAs. There are nine patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Travoprost has one hundred and thirty-four patent family members in twenty-five countries.

There are fifteen drug master file entries for travoprost. Nine suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for travoprost

See drug prices for travoprost

Drug Sales Revenue Trends for travoprost

See drug sales revenues for travoprost

Recent Clinical Trials for travoprost

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Salus UniversityPhase 4
Assiut UniversityPhase 4
Glaukos CorporationPhase 3

See all travoprost clinical trials

Generic filers with tentative approvals for TRAVOPROST
Applicant Application No. Strength Dosage Form
⤷  Try a Trial⤷  Try a Trial0.004%SOLUTION; OPHTHALMIC

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for travoprost
Medical Subject Heading (MeSH) Categories for travoprost
Anatomical Therapeutic Chemical (ATC) Classes for travoprost
Paragraph IV (Patent) Challenges for TRAVOPROST
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
IZBA Ophthalmic Solution travoprost 0.003% 204822 1 2015-12-30
TRAVATAN Z Ophthalmic Solution travoprost 0.004% 021994 1 2009-02-19
TRAVATAN Ophthalmic Solution travoprost 0.004% 021257 1 2008-11-28

US Patents and Regulatory Information for travoprost

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis IZBA travoprost SOLUTION/DROPS;OPHTHALMIC 204822-001 May 15, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Glaukos IDOSE TR travoprost IMPLANT;INTRACAMERAL 218010-001 Dec 13, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaukos IDOSE TR travoprost IMPLANT;INTRACAMERAL 218010-001 Dec 13, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Novartis IZBA travoprost SOLUTION/DROPS;OPHTHALMIC 204822-001 May 15, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis IZBA travoprost SOLUTION/DROPS;OPHTHALMIC 204822-001 May 15, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Novartis IZBA travoprost SOLUTION/DROPS;OPHTHALMIC 204822-001 May 15, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for travoprost

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
Sandoz TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ⤷  Try a Trial ⤷  Try a Trial
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
Sandoz TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ⤷  Try a Trial ⤷  Try a Trial
Sandoz TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ⤷  Try a Trial ⤷  Try a Trial
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

EU/EMA Drug Approvals for travoprost

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Novartis Europharm Limited Izba travoprost EMEA/H/C/002738
Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma.
Authorised no no no 2014-02-20
Novartis Europharm Limited Travatan travoprost EMEA/H/C/000390
Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1).Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1).
Authorised no no no 2001-11-27
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for travoprost

Country Patent Number Title Estimated Expiration
Taiwan I394564 ⤷  Try a Trial
European Patent Office 2432420 IMPLANT OCULAIRE À ÉLUTION DE MÉDICAMENT (DRUG ELUTING OCULAR IMPLANT) ⤷  Try a Trial
China 101516332 Self preserved aqueous pharmaceutical compositions ⤷  Try a Trial
Russian Federation 2436568 САМОКОНСЕРВИРУЮЩИЕСЯ ВОДНЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ (SELF-PRESERVED WATER PHARMACEUTICAL COMPOSITIONS) ⤷  Try a Trial
Taiwan I544927 ⤷  Try a Trial
Poland 2265251 ⤷  Try a Trial
China 102655823 Drug eluting ocular implant ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for travoprost

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1920764 1290027-0 Sweden ⤷  Try a Trial PRODUCT NAME: TRAVOPROST
1514548 CA 2014 00038 Denmark ⤷  Try a Trial PRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127
1514548 PA2014029 Lithuania ⤷  Try a Trial PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
1920764 C01920764/01 Switzerland ⤷  Try a Trial PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
1920764 PA2012017,C1920764 Lithuania ⤷  Try a Trial PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
1920764 SPC/GB12/038 United Kingdom ⤷  Try a Trial PRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129
1920764 PA2012017 Lithuania ⤷  Try a Trial PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.